Loading data
XZONYSE
| Unit: USD | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 216.98 m USD | 133.95 m USD | 88.33 m USD |
| Cost of revenue | 85.96 m USD | 80.74 m USD | 71.06 m USD |
| Gross profit | 131.02 m USD | 53.21 m USD | 17.27 m USD |
| Research and development expense | 8.83 m USD | 6.51 m USD | 6.53 m USD |
| Selling, general and administrative expense | 15.72 m USD | 8.34 m USD | 7.9 m USD |
| Operating profit | 105.99 m USD | 38.02 m USD | 2.55 m USD |
| Profit before tax | 110.29 m USD | 35.24 m USD | 883 k USD |
| Income tax expense | 27.54 m USD | 9.17 m USD | -12.02 m USD |
| Net income (reported basis) | 82.75 m USD | 45.32 m USD | 21.46 m USD |
| Net income attributable to common shareholders | 82.75 m USD | 35.17 m USD | 12.09 m USD |
| Basic earnings per share | 0.99 USD/share | 0.44 USD/share | 0.15 USD/share |
| Diluted earnings per share | 0.99 USD/share | 0.44 USD/share | 0.15 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.